Skip to main content
Zur Rose Group AG logo

Zur Rose Group AG — Investor Relations & Filings

Ticker · ROSE ISIN · CH0042615283 LEI · 50670038OH136R5Z4663 SW Wholesale and retail trade
Open in API
Filings indexed 477 across all filing types
Latest filing 2026-01-20 Earnings Release
Country CH Switzerland
Listing SW ROSE

About Zur Rose Group AG

https://www.zurrosegroup.com/websites/z…

DocMorris AG, formerly Zur Rose Group AG, is a leading European e-commerce pharmacy. The company provides an online platform for medicines and develops digital health services. Its core strategy involves creating a comprehensive digital health ecosystem that connects patients, doctors, pharmacies, and health insurers on a single platform. The company's vision is to enable individuals to manage their health with a single click, offering integrated care and treatment solutions. Originally founded as a pharmacy wholesaler, it has evolved to focus on the digitalization of healthcare services.

Recent filings

Filing Released Lang Actions
DocMorris achieves 11.1 per cent revenue growth in 2025 strong fourth quarter
Earnings Release Classification · 100% confidence The document is a press release titled 'DocMorris achieves 11.1 per cent revenue growth in 2025 – strong fourth quarter'. It provides preliminary, unaudited financial highlights, revenue figures, and growth metrics for the full year and the fourth quarter of 2025. It is an initial announcement of financial results rather than a full annual report or a transcript. According to the filing definitions, this fits the 'Earnings Release' (ER) category as it focuses on key financial highlights and performance metrics. FY 2025
2026-01-20 English
DocMorris achieves 11.1 per cent revenue growth in 2025 – strong fourth quarter
Earnings Release Classification · 100% confidence The document is a press release from DocMorris AG announcing preliminary, unaudited revenue figures for the 2025 financial year and the fourth quarter. It highlights key performance metrics, growth percentages, and management commentary. It is clearly an initial announcement of financial results rather than a full annual report or a transcript of a call. According to the filing definitions, this fits the 'Earnings Release' (ER) category, as it provides key highlights of financial performance for a specific period. FY 2025
2026-01-20 English
DocMorris erzielt 2025 Umsatzplus von 11.1 Prozent – starkes viertes Quartal
Earnings Release Classification · 100% confidence The document is a press release titled 'DocMorris erzielt 2025 Umsatzplus von 11.1 Prozent' (DocMorris achieves 11.1 percent sales growth in 2025). It provides preliminary, unaudited financial highlights for the fiscal year 2025 and the fourth quarter, including revenue growth, segment performance, and management commentary. It is clearly an initial announcement of financial results rather than a full annual report or a report publication announcement. Therefore, it fits the definition of an Earnings Release (ER). FY 2025
2026-01-20 German
DocMorris announces the results of the tender offer for its Outstanding Convertible Bonds due 2026
Capital/Financing Update Classification · 100% confidence The document is a press release announcing the results of a tender offer for convertible bonds. It details the number of bonds tendered, the purchase price, and the settlement date. This falls under the category of capital structure and financing activities. Since it is a specific announcement regarding a financing transaction rather than a general regulatory filing or a report publication announcement, it is best classified as a Capital/Financing Update (CAP).
2025-11-13 English
DocMorris announces the results of the tender offer for its Outstanding Convertible Bonds due 2026
Capital/Financing Update Classification · 100% confidence The document is a press release announcing the results of a tender offer for convertible bonds. It details the number of bonds tendered, the purchase price, and the settlement date. This falls under financing activities and capital structure changes. According to the filing definitions, 'CAP' (Capital/Financing Update) is the appropriate category for updates on company financing activities.
2025-11-13 English
DocMorris gibt die Ergebnisse des Rückkaufangebots für die ausstehenden Wandelanleihen mit Fälligkeit 2026 bekannt
Capital/Financing Update Classification · 100% confidence The document is a press release from DocMorris AG announcing the results of a tender offer (buyback) for its outstanding convertible bonds due in 2026. It details the number of bonds tendered, the purchase price, and the settlement date. This falls under the category of capital structure changes and financing updates, specifically related to debt management. It is not a report publication announcement, but rather the announcement of the transaction results itself.
2025-11-13 German

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.